THX Pharma Société Anonyme (ENXTPA: ALTHX)
Health Care · Pharmaceuticals · FR
€4.24
+3.80% today · +72.9% 1Y
THX Pharma Société Anonyme (ENXTPA: ALTHX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $68.21M and employs 12 people.
Over the last twelve months the share price has gained 72.9%, trading between 1.49 and 5.10.
Tweenvest scores THX Pharma Société Anonyme across four factors: quality 25/100, value 73/100. Its strongest factor is value.
ALTHX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $68.21M
- Revenue (TTM)
- $946.39K
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 1.52
- 52-week high
- €5.10
- 52-week low
- €1.49
- Avg volume (3M)
- —
- Shares outstanding
- 13.80M
- Employees
- 12
- Next earnings
- —
About THX Pharma Société Anonyme
Theranexus, a biopharmaceutical enterprise, specializes in the creation of potential medications for ailments affecting the central nervous system. Their primary investigational compound, THN102, is presently undergoing Phase II clinical evaluation for conditions related to sleep and wake cycles. Furthermore, they are developing THN201 to target neurocognitive challenges associated with Alzheimer's disease, and THN101 for the management of neuropathic discomfort. This company commenced operations in 2013 and is situated in Lyon, France.
- ISIN
- FR0013286259
- Founded
- 2013
- Listed since
- Oct 30, 2017
- Exchange
- Euronext Paris
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.